Your browser doesn't support javascript.
loading
4'-Fluorouridine mitigates lethal infection with pandemic human and highly pathogenic avian influenza viruses.
Lieber, Carolin M; Aggarwal, Megha; Yoon, Jeong-Joong; Cox, Robert M; Kang, Hae-Ji; Sourimant, Julien; Toots, Mart; Johnson, Scott K; Jones, Cheryl A; Sticher, Zachary M; Kolykhalov, Alexander A; Saindane, Manohar T; Tompkins, Stephen M; Planz, Oliver; Painter, George R; Natchus, Michael G; Sakamoto, Kaori; Plemper, Richard K.
Afiliação
  • Lieber CM; Center for Translational Antiviral Research, Georgia State University Institute for Biomedical Sciences, Atlanta, Georgia, United States of America.
  • Aggarwal M; Center for Translational Antiviral Research, Georgia State University Institute for Biomedical Sciences, Atlanta, Georgia, United States of America.
  • Yoon JJ; Center for Translational Antiviral Research, Georgia State University Institute for Biomedical Sciences, Atlanta, Georgia, United States of America.
  • Cox RM; Center for Translational Antiviral Research, Georgia State University Institute for Biomedical Sciences, Atlanta, Georgia, United States of America.
  • Kang HJ; Center for Translational Antiviral Research, Georgia State University Institute for Biomedical Sciences, Atlanta, Georgia, United States of America.
  • Sourimant J; Center for Translational Antiviral Research, Georgia State University Institute for Biomedical Sciences, Atlanta, Georgia, United States of America.
  • Toots M; Center for Translational Antiviral Research, Georgia State University Institute for Biomedical Sciences, Atlanta, Georgia, United States of America.
  • Johnson SK; Center for Vaccines and Immunology, University of Georgia, Athens, Georgia, United States of America.
  • Jones CA; Center for Vaccines and Immunology, University of Georgia, Athens, Georgia, United States of America.
  • Sticher ZM; Emory Institute for Drug Development, Emory University, Atlanta, Georgia, United States of America.
  • Kolykhalov AA; Emory Institute for Drug Development, Emory University, Atlanta, Georgia, United States of America.
  • Saindane MT; Emory Institute for Drug Development, Emory University, Atlanta, Georgia, United States of America.
  • Tompkins SM; Center for Vaccines and Immunology, University of Georgia, Athens, Georgia, United States of America.
  • Planz O; Department of Immunology, Interfaculty Institute for Cell Biology, Eberhard Karls University Tübingen, Tübingen, Germany.
  • Painter GR; Emory Institute for Drug Development, Emory University, Atlanta, Georgia, United States of America.
  • Natchus MG; Emory Institute for Drug Development, Emory University, Atlanta, Georgia, United States of America.
  • Sakamoto K; Department of Pathology, College of Veterinary Medicine, University of Georgia, Athens, Georgia, United States of America.
  • Plemper RK; Center for Translational Antiviral Research, Georgia State University Institute for Biomedical Sciences, Atlanta, Georgia, United States of America.
PLoS Pathog ; 19(4): e1011342, 2023 04.
Article em En | MEDLINE | ID: mdl-37068076
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Vírus da Influenza A / Vírus Sincicial Respiratório Humano / Infecções por Orthomyxoviridae / Influenza Humana / Vírus da Influenza A Subtipo H1N1 / Virus da Influenza A Subtipo H5N1 / COVID-19 Limite: Animals / Humans Idioma: En Revista: PLoS Pathog Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Vírus da Influenza A / Vírus Sincicial Respiratório Humano / Infecções por Orthomyxoviridae / Influenza Humana / Vírus da Influenza A Subtipo H1N1 / Virus da Influenza A Subtipo H5N1 / COVID-19 Limite: Animals / Humans Idioma: En Revista: PLoS Pathog Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos